- Home
- PRTA vs MYN Comparison
PRTA vs MYN Comparison
Compare PRTA & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MYN
- Stock Information
- Founded
- PRTA 2012
- MYN 1992
- Country
- PRTA Ireland
- MYN United States
- Employees
- PRTA N/A
- MYN N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MYN Finance Companies
- Sector
- PRTA Health Care
- MYN Finance
- Exchange
- PRTA Nasdaq
- MYN Nasdaq
- Market Cap
- PRTA 472.1M
- MYN 358.2M
- IPO Year
- PRTA N/A
- MYN N/A
- Fundamental
- Price
- PRTA $8.20
- MYN $9.31
- Analyst Decision
- PRTA Buy
- MYN
- Analyst Count
- PRTA 10
- MYN 0
- Target Price
- PRTA $14.86
- MYN N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- MYN 86.0K
- Earning Date
- PRTA 08-04-2025
- MYN 01-01-0001
- Dividend Yield
- PRTA N/A
- MYN 4.12%
- EPS Growth
- PRTA N/A
- MYN N/A
- EPS
- PRTA N/A
- MYN N/A
- Revenue
- PRTA $10,341,000.00
- MYN N/A
- Revenue This Year
- PRTA N/A
- MYN N/A
- Revenue Next Year
- PRTA $389.77
- MYN N/A
- P/E Ratio
- PRTA N/A
- MYN N/A
- Revenue Growth
- PRTA N/A
- MYN N/A
- 52 Week Low
- PRTA $4.32
- MYN $8.47
- 52 Week High
- PRTA $22.83
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- MYN 48.18
- Support Level
- PRTA $8.05
- MYN $9.20
- Resistance Level
- PRTA $8.73
- MYN $9.33
- Average True Range (ATR)
- PRTA 0.38
- MYN 0.07
- MACD
- PRTA -0.05
- MYN -0.01
- Stochastic Oscillator
- PRTA 47.62
- MYN 50.00
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.